The Genetic Relationship Between Alcohol Consumption and Aspects of Problem Drinking in an Ascertained Sample.


Journal

Alcoholism, clinical and experimental research
ISSN: 1530-0277
Titre abrégé: Alcohol Clin Exp Res
Pays: England
ID NLM: 7707242

Informations de publication

Date de publication:
06 2019
Historique:
received: 24 10 2018
accepted: 04 04 2019
pubmed: 18 4 2019
medline: 4 9 2020
entrez: 18 4 2019
Statut: ppublish

Résumé

Genomewide association studies (GWAS) have begun to identify loci related to alcohol consumption, but little is known about whether this genetic propensity overlaps with specific indices of problem drinking in ascertained samples. In 6,731 European Americans who had been exposed to alcohol, we examined whether polygenic risk scores (PRS) from a GWAS of weekly alcohol consumption in the UK Biobank predicted variance in 6 alcohol-related phenotypes: alcohol use, maximum drinks within 24 hours (MAXD), total score on the Self-Rating of the Effects of Ethanol Questionnaire (SRE-T), DSM-IV alcohol dependence (DSM4AD), DSM-5 alcohol use disorder symptom counts (DSM5AUDSX), and reduction/cessation of problematic drinking. We also examined the extent to which an single nucleotide polymorphism (rs1229984) in ADH1B, which is strongly associated with both alcohol consumption and dependence, contributed to the polygenic association with these phenotypes and whether PRS interacted with sex, age, or family history of alcoholism to predict alcohol-related outcomes. We performed mixed-effect regression analyses, with family membership and recruitment site included as random effects, as well as survival modeling of age of onset of DSM4AD. PRS for alcohol consumption significantly predicted variance in 5 of the 6 outcomes: alcohol use (Δmarginal R Genetic propensity for typical alcohol consumption was associated with alcohol use and was also associated with 4 of the additional 5 outcomes, though the variance explained in this sample was modest. Future GWAS that focus on the multifaceted nature of AUD, which goes beyond consumption, might reveal additional information regarding the polygenic underpinnings of problem drinking.

Sections du résumé

BACKGROUND
Genomewide association studies (GWAS) have begun to identify loci related to alcohol consumption, but little is known about whether this genetic propensity overlaps with specific indices of problem drinking in ascertained samples.
METHODS
In 6,731 European Americans who had been exposed to alcohol, we examined whether polygenic risk scores (PRS) from a GWAS of weekly alcohol consumption in the UK Biobank predicted variance in 6 alcohol-related phenotypes: alcohol use, maximum drinks within 24 hours (MAXD), total score on the Self-Rating of the Effects of Ethanol Questionnaire (SRE-T), DSM-IV alcohol dependence (DSM4AD), DSM-5 alcohol use disorder symptom counts (DSM5AUDSX), and reduction/cessation of problematic drinking. We also examined the extent to which an single nucleotide polymorphism (rs1229984) in ADH1B, which is strongly associated with both alcohol consumption and dependence, contributed to the polygenic association with these phenotypes and whether PRS interacted with sex, age, or family history of alcoholism to predict alcohol-related outcomes. We performed mixed-effect regression analyses, with family membership and recruitment site included as random effects, as well as survival modeling of age of onset of DSM4AD.
RESULTS
PRS for alcohol consumption significantly predicted variance in 5 of the 6 outcomes: alcohol use (Δmarginal R
CONCLUSIONS
Genetic propensity for typical alcohol consumption was associated with alcohol use and was also associated with 4 of the additional 5 outcomes, though the variance explained in this sample was modest. Future GWAS that focus on the multifaceted nature of AUD, which goes beyond consumption, might reveal additional information regarding the polygenic underpinnings of problem drinking.

Identifiants

pubmed: 30994927
doi: 10.1111/acer.14064
pmc: PMC6560626
mid: NIHMS1024239
doi:

Substances chimiques

Central Nervous System Depressants 0
Ethanol 3K9958V90M

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1113-1125

Subventions

Organisme : NIAAA NIH HHS
ID : F32 AA027435
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH109532
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH109536
Pays : United States
Organisme : NIAAA NIH HHS
ID : U10 AA008401
Pays : United States

Informations de copyright

© 2019 by the Research Society on Alcoholism.

Références

Nat Commun. 2019 May 17;10(1):2275
pubmed: 31101824
Alcohol Health Res World. 1995;19(3):228-236
pubmed: 31798102
Addict Biol. 2019 Jan;24(1):121-131
pubmed: 29058377
J Stud Alcohol Drugs. 2009 Mar;70(2):157-68
pubmed: 19261227
Am J Hum Genet. 2017 Apr 6;100(4):635-649
pubmed: 28366442
Mol Psychiatry. 2012 Dec;17(12):1306-15
pubmed: 22105626
Mol Psychiatry. 2012 Apr;17(4):445-50
pubmed: 21968928
J Stud Alcohol. 1994 Mar;55(2):149-58
pubmed: 8189735
Nat Rev Genet. 2013 Jul;14(7):507-15
pubmed: 23774735
Am J Psychiatry. 2007 Aug;164(8):1149-59
pubmed: 17671276
Annu Rev Clin Psychol. 2018 May 7;14:119-157
pubmed: 29579395
Alcohol Clin Exp Res. 2018 Sep;42(9):1704-1714
pubmed: 29975427
Alcohol Clin Exp Res. 2018 May;42(5):822-835
pubmed: 29623680
Alcohol Clin Exp Res. 2012 Jun;36(6):1034-41
pubmed: 22235947
Alcohol Clin Exp Res. 2011 Dec;35(12):2152-61
pubmed: 21689117
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Addiction. 2017 Nov;112(11):1909-1917
pubmed: 28556494
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Nat Neurosci. 2018 Dec;21(12):1656-1669
pubmed: 30482948
Mol Psychiatry. 2017 Oct;22(10):1376-1384
pubmed: 28937693
Ann N Y Acad Sci. 1994 Feb 28;708:72-85
pubmed: 8154691
Lancet. 2009 Jun 27;373(9682):2223-33
pubmed: 19560604
Nat Genet. 2015 Nov;47(11):1236-41
pubmed: 26414676
Alcohol Clin Exp Res. 2010 Jun;34(6):1058-65
pubmed: 20374207
Drug Alcohol Depend. 2018 Feb 1;183:7-12
pubmed: 29220643
Alcohol Clin Exp Res. 2018 Mar;42(3):520-530
pubmed: 29405378
PLoS Genet. 2013 Mar;9(3):e1003348
pubmed: 23555274
Neuropsychopharmacology. 2014 Jan;39(2):254-62
pubmed: 24121188
Addiction. 1999 Sep;94(9):1361-70
pubmed: 10615721
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
Psychol Bull. 2006 Jul;132(4):607-21
pubmed: 16822169
Alcohol Clin Exp Res. 2018 Dec;42(12):2349-2359
pubmed: 30276832
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14372-14377
pubmed: 27911795
Nat Neurosci. 2014 Jun;17(6):782-90
pubmed: 24866044
Alcohol Clin Exp Res. 2018 Dec;42(12):2281-2297
pubmed: 30320893
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7119-24
pubmed: 21471458
Am J Hum Genet. 2004 Apr;74(4):765-9
pubmed: 14997420
Drug Alcohol Depend. 2013 Mar 1;128(3):194-9
pubmed: 22980675
Int J Epidemiol. 2016 Oct;45(5):1600-1616
pubmed: 27342221
Biol Psychiatry. 2014 Jan 1;75(1):18-24
pubmed: 24135711
Psychol Med. 2015 Apr;45(5):1061-72
pubmed: 25171596
Alcohol Res Health. 2007;30(1):5-13
pubmed: 17718394
J Stud Alcohol Drugs. 2011 May;72(3):444-52
pubmed: 21513681
J Child Psychol Psychiatry. 2014 Oct;55(10):1068-87
pubmed: 25132410
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Addiction. 2011 Mar;106(3):657-69
pubmed: 21077975
Biol Psychiatry. 2009 Oct 15;66(8):795-800
pubmed: 19576574
Am J Hum Genet. 1998 Jul;63(1):259-66
pubmed: 9634505
Addiction. 1997 Aug;92(8):979-88
pubmed: 9376780
Am J Psychiatry. 2019 Feb 1;176(2):107-118
pubmed: 30336701
Mol Psychiatry. 2017 Sep;22(9):1359-1367
pubmed: 28485404
Alcohol Alcohol. 2008 Nov-Dec;43(6):641-6
pubmed: 18845530
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
J Stud Alcohol Drugs. 2016 Mar;77(2):185-98
pubmed: 26997174
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
Am J Psychiatry. 1999 Jan;156(1):34-40
pubmed: 9892295
Alcohol Clin Exp Res. 2017 Feb;41(2):359-368
pubmed: 28073157
Alcohol Clin Exp Res. 2013 Aug;37(8):1424-31
pubmed: 23458300
Nat Methods. 2013 Jan;10(1):5-6
pubmed: 23269371
JAMA Psychiatry. 2015 Jul;72(7):635-41
pubmed: 25830477
PLoS One. 2016 Nov 30;11(11):e0167360
pubmed: 27902751
Transl Psychiatry. 2014 Oct 07;4:e462
pubmed: 25290263

Auteurs

Emma C Johnson (EC)

Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri.

Celine L St Pierre (CL)

Division of Biological and Biomedical Sciences, Washington University School of Medicine, Saint Louis, Missouri.

Jacquelyn L Meyers (JL)

Henri Begleiter Neurodynamics Laboratory, Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York.

Fazil Aliev (F)

Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia.
Department of Actuarial and Risk Management, Faculty of Business, Karabuk University, Karabük, Turkey.

Vivia V McCutcheon (VV)

Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri.

Dongbing Lai (D)

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.

Danielle M Dick (DM)

Department of Psychology and Human and Molecular Genetics, Virginia Commonwealth University, Richmond, Virginia.

Alison M Goate (AM)

Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.

John Kramer (J)

Department of Psychiatry, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Samuel Kuperman (S)

Department of Psychiatry, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, Iowa.

John I Nurnberger (JI)

Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana.

Marc A Schuckit (MA)

Department of Psychiatry, University of California San Diego, San Diego, California.

Bernice Porjesz (B)

Henri Begleiter Neurodynamics Laboratory, Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York.

Howard J Edenberg (HJ)

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana.

Kathleen K Bucholz (KK)

Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri.

Arpana Agrawal (A)

Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH